 Bethany Veo
Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 4 | 2023 | 156 | 1.090 |
Why?
| | Medulloblastoma | 4 | 2023 | 198 | 1.070 |
Why?
| | Peptide Chain Initiation, Translational | 2 | 2012 | 42 | 0.700 |
Why?
| | tau Proteins | 2 | 2012 | 78 | 0.680 |
Why?
| | DNA Repair | 1 | 2021 | 206 | 0.640 |
Why?
| | RNA, Messenger | 3 | 2012 | 2679 | 0.470 |
Why?
| | Repressor Proteins | 4 | 2019 | 401 | 0.410 |
Why?
| | Ribosome Subunits, Small, Eukaryotic | 1 | 2012 | 8 | 0.410 |
Why?
| | Receptors, Dopamine D2 | 2 | 2019 | 89 | 0.300 |
Why?
| | Caenorhabditis elegans Proteins | 3 | 2013 | 191 | 0.240 |
Why?
| | Glioblastoma | 2 | 2019 | 326 | 0.220 |
Why?
| | Caenorhabditis elegans | 3 | 2013 | 291 | 0.180 |
Why?
| | Gene Expression Regulation | 2 | 2012 | 2516 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 130 | 0.170 |
Why?
| | Cell Line, Tumor | 4 | 2023 | 3178 | 0.160 |
Why?
| | RNA Cap Analogs | 2 | 2010 | 6 | 0.160 |
Why?
| | Neuroblastoma | 2 | 2012 | 153 | 0.160 |
Why?
| | Cell Proliferation | 3 | 2022 | 2345 | 0.160 |
Why?
| | Brain Neoplasms | 2 | 2019 | 1172 | 0.150 |
Why?
| | Nucleic Acid Conformation | 2 | 2012 | 706 | 0.140 |
Why?
| | Locomotion | 1 | 2018 | 99 | 0.140 |
Why?
| | Corpus Striatum | 1 | 2018 | 158 | 0.130 |
Why?
| | Pharynx | 2 | 2013 | 57 | 0.120 |
Why?
| | DNA-Binding Proteins | 3 | 2013 | 1423 | 0.120 |
Why?
| | SOXB1 Transcription Factors | 1 | 2015 | 57 | 0.120 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 380 | 0.120 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1179 | 0.120 |
Why?
| | Forkhead Transcription Factors | 1 | 2015 | 181 | 0.120 |
Why?
| | RNA, Small Interfering | 3 | 2015 | 573 | 0.110 |
Why?
| | Neural Stem Cells | 1 | 2015 | 142 | 0.110 |
Why?
| | Animals | 10 | 2021 | 34647 | 0.110 |
Why?
| | Mice | 6 | 2021 | 16620 | 0.110 |
Why?
| | Organogenesis | 1 | 2013 | 56 | 0.100 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2015 | 325 | 0.100 |
Why?
| | RNA, Ribosomal | 1 | 2012 | 162 | 0.100 |
Why?
| | Embryonic Stem Cells | 1 | 2012 | 119 | 0.090 |
Why?
| | Pluripotent Stem Cells | 1 | 2012 | 78 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 570 | 0.090 |
Why?
| | Eukaryotic Initiation Factor-4G | 1 | 2010 | 5 | 0.080 |
Why?
| | Trans-Splicing | 1 | 2010 | 12 | 0.080 |
Why?
| | Eukaryotic Initiation Factor-4E | 1 | 2010 | 27 | 0.080 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 837 | 0.080 |
Why?
| | Neurons | 1 | 2018 | 1447 | 0.080 |
Why?
| | Luciferases, Firefly | 1 | 2009 | 3 | 0.080 |
Why?
| | Luciferases, Renilla | 1 | 2009 | 5 | 0.080 |
Why?
| | Cycloheximide | 1 | 2009 | 56 | 0.080 |
Why?
| | MicroRNAs | 1 | 2015 | 674 | 0.080 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2009 | 44 | 0.080 |
Why?
| | Phosphorylation | 1 | 2012 | 1686 | 0.070 |
Why?
| | Rabbits | 1 | 2009 | 775 | 0.070 |
Why?
| | Alzheimer Disease | 1 | 2012 | 517 | 0.070 |
Why?
| | Transfection | 1 | 2009 | 896 | 0.070 |
Why?
| | Humans | 8 | 2023 | 128495 | 0.060 |
Why?
| | Mutation | 2 | 2012 | 3696 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 1951 | 0.060 |
Why?
| | Survival Rate | 2 | 2019 | 1871 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 218 | 0.050 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 168 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 45 | 0.050 |
Why?
| | Apoptosis | 2 | 2022 | 2437 | 0.050 |
Why?
| | Sequence Alignment | 2 | 2013 | 330 | 0.050 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2023 | 433 | 0.040 |
Why?
| | Transcription Factors | 1 | 2009 | 1635 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 243 | 0.040 |
Why?
| | Piperazines | 1 | 2022 | 333 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 3780 | 0.040 |
Why?
| | Nuclear Proteins | 1 | 2023 | 658 | 0.040 |
Why?
| | Pyrazoles | 1 | 2022 | 404 | 0.040 |
Why?
| | Gene Knock-In Techniques | 1 | 2018 | 52 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 633 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 581 | 0.040 |
Why?
| | Base Sequence | 2 | 2013 | 2137 | 0.040 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 819 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2018 | 226 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2019 | 478 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 930 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2013 | 2822 | 0.030 |
Why?
| | Models, Animal | 1 | 2018 | 367 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 812 | 0.030 |
Why?
| | Cell Differentiation | 2 | 2015 | 1900 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 428 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2015 | 128 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 129 | 0.030 |
Why?
| | Ligases | 1 | 2013 | 30 | 0.030 |
Why?
| | Mice, Nude | 1 | 2015 | 678 | 0.030 |
Why?
| | Cerebellum | 1 | 2015 | 217 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2015 | 757 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2019 | 1349 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2018 | 2069 | 0.030 |
Why?
| | Child | 2 | 2023 | 20805 | 0.030 |
Why?
| | Blotting, Western | 1 | 2015 | 1170 | 0.030 |
Why?
| | Cell Dedifferentiation | 1 | 2012 | 30 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2013 | 504 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1027 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 153 | 0.020 |
Why?
| | Zinc Fingers | 1 | 2012 | 44 | 0.020 |
Why?
| | Muscle Cells | 1 | 2012 | 39 | 0.020 |
Why?
| | Extracellular Space | 1 | 2012 | 119 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 441 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 311 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1689 | 0.020 |
Why?
| | Microtubules | 1 | 2013 | 259 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2015 | 1668 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2013 | 775 | 0.020 |
Why?
| | Cell-Free System | 1 | 2010 | 47 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2012 | 345 | 0.020 |
Why?
| | Male | 4 | 2019 | 63043 | 0.020 |
Why?
| | Guanosine | 1 | 2010 | 40 | 0.020 |
Why?
| | 5' Untranslated Regions | 1 | 2010 | 55 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2044 | 0.020 |
Why?
| | RNA Stability | 1 | 2010 | 100 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4017 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2010 | 398 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 7057 | 0.020 |
Why?
| | Genomics | 1 | 2012 | 715 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 3051 | 0.020 |
Why?
| | Cell Line | 1 | 2012 | 2741 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2015 | 3947 | 0.020 |
Why?
| | Time Factors | 1 | 2012 | 6505 | 0.010 |
Why?
| | Female | 2 | 2019 | 68266 | 0.010 |
Why?
| | Biomarkers | 1 | 2012 | 3893 | 0.010 |
Why?
| | Aged | 1 | 2019 | 21974 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2015 | 14471 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 30921 | 0.010 |
Why?
|
|
Veo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|